AI-Designed Personalized mRNA Therapy Cuts Melanoma Recurrence Risk
An AI-designed personalized mRNA therapy has reduced melanoma recurrence, metastasis and death, BioXconomy reports; effect sizes and trial details remain unstated.
Topic
Neoantigen Therapy
Topic
Neoantigen Therapy
Personalised mRNA Vaccine Stops Melanoma Returning in Reported Breakthrough
A personalised mRNA cancer vaccine stopped melanoma from returning, Gavi reports, marking a milestone for individualised neoantig…
Personalized Melanoma Vaccine Cuts Recurrence Risk in Phase 3
A personalized neoantigen vaccine met its primary endpoint, reducing melanoma recurrence risk after resection in a phase 3 trial…